Psoriasis Linked to Lower Fertility Rate, Increased Risk of Pregnancy Loss
https://reachmd.com/news/psoriasis-linked-to-lower-fertility-rate-increased-risk-of-pregnancy-loss/2452453/
In a study comparing fertility rates and obstetric outcomes of pregnancies in female patients with or without psoriasis, lower fertility rates and higher risk of pregnancy loss were seen at greater rates among patients with moderate to severe psoriasis.This population-based cohort study is publishe…
Virogentics Inc. Announces Pilot Clinical Trial of ITV-1 at National Center for Endocrinology in Bulgaria & Expansion of Nutraceutical Line
https://reachmd.com/news/virogentics-inc-announces-pilot-clinical-trial-of-itv-1-at-national-center-for-endocrinology-in-bulgaria-expansion-of-nutraceutical-line/2451223/
COLLEGE STATION, TX / ACCESSWIRE / May 8, 2023 / Enzolytics, Inc. (OTC PINK:ENZC) (https://enzolytics.com/).Enzolytics, Inc. (the "Company" or "ENZC"), a drug development biotech company, announced that the Company's wholly owned subsidiary, Virogenetics (VIRO), will be conducting a pilot clinical …
Dementia the Top COVID-19 Risk Factor for Seniors in Care
https://reachmd.com/news/dementia-the-top-covid-19-risk-factor-for-seniors-in-care/2450439/
Newswise — In 2020, the first year of the COVID-19 pandemic, dementia was the dominant risk factor for the disease among residents of Swedish nursing homes. This elevated risk applied to both getting infected with and dying of COVID-19, a University of Gothenburg study shows.The purpose of the stu…
SELECT Trial: Semaglutide Lowers CVD Risk in Patients with Obesity
https://reachmd.com/programs/heart-matters/select-trial-semaglutide-lowers-cvd-risk-in-patients-with-obesity/16173/
A new study shows the potential of semaglutide for lowering cardiovascular disease risk in patients with obesity. Here are the findings from SELECT.
Highlights from ENDO, the 95th Annual Meeting of The Endocrine Society
https://reachmd.com/programs/conference-coverage/highlights-from-endo-the-95th-annual-meeting-of-the-endocrine-society/6824/
Highlights from ENDO, the 95th Annual Meeting of The Endocrine Society. The Endocrine Society is the world's oldest, largest, and most active organization devoted to research on hormones and the clinical practice of endocrinology. Download the program to hear global thought leaders discuss the newe
Weekly Check-up | August 15th 2016
https://reachmd.com/programs/the-weekly-check-up/weekly-check-august-15th-2016/8282/
Welcome to the Weekly Check-up on ReachMD for the week of August 15th, 2016.
Weekly Check-up | April 11th 2016
https://reachmd.com/programs/the-weekly-check-up/weekly-check-april-11th-2016/8048/
Welcome to the Weekly Check-up on ReachMD for the week of April 4th, 2016.
Reducing Retina Treatment Burden in the Real World: Emerging Evidence with Treatment Advances
https://reachmd.com/programs/cme/reducing-retina-treatment-burden-in-the-real-world-emerging-evidence-with-treatment-advances/15477/
What do real-world data say about new, durable treatments for nAMD and DME? Our experts offer bite-sized updates and strategies you can use today!
Case-Based Management of Hyperkalemia to Optimize RAASi Therapy in Patients with CKD
https://reachmd.com/programs/cme/case-based-management-of-hyperkalemia-to-optimize-raasi-therapy-in-patients-with-ckd/16624/
Join our experts as they discuss the management of hyperkalemia in patients with CKD to enable guideline-recommended RASi therapy.
Treating Obesity as a Chronic Disease
https://reachmd.com/programs/cme/treating-obesity-as-a-chronic-disease/16389/
Experts review guideline-recommended criteria for diagnosis and treatment of obesity and describe best practices for prioritization of obesity management.